title: High prevalence of target organ damage in young, African American inner-city men with hypertension.
abstract: Young, urban, African American men are at particularly high risk of hypertension and its cardiovascular complications. Left ventricular hypertrophy and renal dysfunction are manifestations of target organ damage from hypertension that predict adverse cardiovascular events. The subjects of this study were 309 African American men, age 18-54 years, with hypertension, residing in inner-city Baltimore. Echocardiograms, electrocardiograms, serum creatinine, and the urinary albumin-creatinine ratio were obtained to evaluate hypertensive target organ damage. Fifty-three percent of the men reported use of antihypertensive medications, of whom 80% were on monotherapy. Calcium channel blockers were used most frequently. The mean echocardiographic left ventricular mass was 211+/-68 g, with a prevalence of echocardiographic left ventricular hypertrophy of 30%. There were 14 men (5%) with extremely high left ventricular mass, >350 grams. Left ventricular systolic dysfunction was seen in 9% of the men with uncontrolled hypertension, and none of the men with controlled hypertension (p=0.02). Renal dysfunction was found in 12% of the subjects, and microalbuminuria or gross proteinuria in 34%. The authors conclude that there is a high prevalence of cardiac and renal abnormalities in inner-city African American men with hypertension, especially in men on antihypertensive therapy with uncontrolled hypertension. It is imperative that cost-effective medications and culturally acceptable health care delivery programs be developed, tested, and integrated into health systems, with strategies specifically relevant to this high-risk population, to decrease the largely preventable morbidity and mortality associated with hypertension.
authors.affiliation: Department of Medicine, the Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA. wpost@jhmi.edu
authors.forename: Wendy S
authors.initials: WS
authors.lastname: Post
authors.forename: Martha N
authors.initials: MN
authors.lastname: Hill
authors.forename: Cheryl R
authors.initials: CR
authors.lastname: Dennison
authors.forename: James L
authors.initials: JL
authors.lastname: Weiss
authors.forename: Gary
authors.initials: G
authors.lastname: Gerstenblith
authors.forename: Roger S
authors.initials: RS
authors.lastname: Blumenthal
mesh_terms: D000293:Adolescent; D000328:Adult; D000704:Analysis of Variance; D000959:Antihypertensive Agents / Q000627:therapeutic use; D015142:Baltimore / Q000453:epidemiology; D044383:Black People; D016009:Chi-Square Distribution; D004452:Echocardiography; D006801:Humans; D006973:Hypertension / Q000150:complications* / Q000188:drug therapy / Q000453:epidemiology; D017379:Hypertrophy, Left Ventricular / Q000000981:diagnostic imaging / Q000453:epidemiology* / Q000209:etiology*; D007674:Kidney Diseases / Q000453:epidemiology* / Q000209:etiology* / Q000652:urine; D008297:Male; D008875:Middle Aged; D015995:Prevalence; D014505:Urban Population; D001741:Black or African American
chemical_list: D000959:Antihypertensive Agents